Skip to main content
. 2020 Feb 28;2020(2):CD001168. doi: 10.1002/14651858.CD001168.pub3

Dillenburg 2014.

Methods Study design: RCT
Conducted in Brazil
Number of centres: 1
Recruitment period: February 2012 to November 2012
Funding source: supported by Postgraduate Research Group of Porto Alegre University Hospital
Participants Inclusion criteria: aged > 21 years, symptomatic atrophic/erosive OLP, histopathological diagnosis of OLP based on WHO‐based criteria
Exclusion criteria: pregnancy or nursing women, histological signs of dysplasia, OLP therapy in the previous 3 months, amalgam restorations near the lesions and the use of medications associated with oral lichenoid reactions
Group A: randomised 21; analysed 16
Group B: randomised 21; analysed 17
Interventions Group A: clobetasol propionate gel 0.05% 3 times daily for 4 weeks and nystatin 100,000 UI/mL oral rinses 3 times daily
Group B: InGaAIP laser applications, 3 times weekly for 4 weeks (12 sessions) and nystatin 100,000 UI/mL oral rinses 3 times daily
Outcomes Pain (VAS), clinical score (Thongrasom), functional score (Lilleby score – 5 grades), relapse rate, anxiety questionnaire (Beck Anxiety Inventory), adverse effects
Measured once weekly during treatment (days 7, 14, 21 and 30) and 4 weeks (day 60) and 8 weeks (day 90) after treatment
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "The patients were randomly assigned to one of the two treatment groups using computer‐generated random number tables."
Allocation concealment (selection bias) Unclear risk Comment: insufficient information to permit judgement.
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Quote: "The patient was not blinded to the treatment."
Blinding of outcome assessment (detection bias) 
 All outcomes High risk Comment: participants (self‐assessed, pain was primary outcome) were not blinded.
Incomplete outcome data (attrition bias) 
 All outcomes High risk 5/21 (23.8%) participants from Group A and 4/21 (19%) from Group B were lost at follow‐up.
Selective reporting (reporting bias) High risk Comment: data on Beck Anxiety Inventory and Lillebay score not reported or impossible to extract.
Other bias Low risk No other sources of bias identified.